Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why GLAS Stock advanced +1.33% Today — RQD Quant Desk Flash
Glass House Brands Inc. Subordinate Voting Shares (GLAS) carries a Roarable Rating of E (Strong Sell) with 25/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±12.5% realized swing band)
Altman Z-Score 0.38 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a GLAS Turnaround Squeeze
While GLAS currently carries a cautious 25/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.18) and Max Pain ($2.39) forces dealer call-delta covering toward $14.63.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why GLAS Stock advanced +1.33% Today — RQD Quant Desk Flash
Glass House Brands Inc. Subordinate Voting Shares (GLAS) advanced +1.33% to $2.28, trading at 5% of its 52-week range ($1.67 – $13.93). Stretched risk/reward at current multiples (-9% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 5% of its 52-week range ($1.67 – $13.93) with RSI-14 at 13.8 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.28 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 42.3% gross margin and $0 annual free cash flow.
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GLAS)
- ✓Walkthrough of GLAS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
GLAS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -9.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on GLAS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for GLAS. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GLAS)
1. Head-to-Head Health Care Peer Comparison (GLAS vs. NAGE, MDWD, ACB, USNA)
Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Glass House Brands Inc. Subordinate Voting Shares (GLAS) ranks #991 by composite RQD confidence (25/100, grade E) and #578 by equity capitalization ($200.6M). Within this direct 5-issuer industry benchmark cohort, NAGE leads on earnings valuation at 11.4x trailing P/E, while NAGE leads on capital efficiency and profitability with 16.8% ROIC and 64.3% gross margin. NAGE currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with GLAS at 25/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| GLAS
ACTIVE
Glass House Brands Inc. Subordinate Voting Shares | E | 25/100 | — | 42.3% | -9.2% | +1.33% | $200.6M | Benchmark Subject |
| NAGE Niagen Bioscience Inc. | C | 63/100 | 11.4x | 64.3% | 16.8% | -1.57% | $197.8M | /nage-vs-glas → |
| MDWD MediWound Ltd. | C- | 60/100 | — | — | — | +2.21% | $178.9M | /mdwd-vs-glas → |
| ACB Aurora Cannabis Inc. | D+ | 58/100 | — | — | — | 0.00% | $252.8M | /acb-vs-glas → |
| USNA USANA Health Sciences Inc. | C- | 61/100 | 24.6x | 78.3% | 7.9% | -1.91% | $265.0M | /usna-vs-glas → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001848731In its most recent audited fiscal period (FY2025, filed 2025-12-31), Glass House Brands Inc. Subordinate Voting Shares (GLAS) reported GAAP revenue of $182.0M (-9.4% vs. FY2024 revenue of $200.9M , and +13.1% cumulative change since FY2023) , GAAP net income of -$29.7M, operating cash flow of $11.4M, and free cash flow of -$15.7M (-186.9% YoY). On the balance sheet, GLAS closed FY2025 with $318.6M in total assets against $68.6M in total debt (Altman Z-Score: 0.38, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $182.0M | -$29.7M | $11.4M | -$15.7M | $318.6M | $68.6M |
| FY2024 (FY) | 2024-12-31 | $200.9M | $519.0K | $28.4M | $18.1M | $310.5M | $50.6M |
| FY2023 (FY) | 2023-12-31 | $160.8M | -$98.3M | $23.2M | $23.2M | — | — |
3. GLAS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs GLAS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Glass House Brands Inc. Subordinate Voting Shares (NYSE: GLAS) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $2.28 (+1.33% 1D, market cap $200.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 6/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, GLAS ranks #991 in composite RQD confidence.
How does GLAS compare to NAGE and MDWD in the Health Care sector?
Within the Health Care sector (Medicinal Chemicals and Botanical Products), GLAS carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of 42.3%, and ROIC of -9.2%. By comparison, NAGE (Niagen Bioscience Inc.) holds a C grade (63/100 RQD, P/E 11.4x, ROIC 16.8%, cap $197.8M) and MDWD (MediWound Ltd.) posts a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $178.9M). Among the 5-stock peer group, NAGE leads on earnings multiple (11.4x) while NAGE leads on capital efficiency (16.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for GLAS?
Per GLAS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001848731), Glass House Brands Inc. Subordinate Voting Shares generated $182.0M in revenue (-9.4% YoY), -$29.7M in net income, and -$15.7M in free cash flow against $318.6M in total assets and $68.6M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is GLAS trading relative to its 50-day, 200-day, and 52-week technical levels?
GLAS last traded at $2.28 (+1.33% on volume of 901,556 shares), positioning the stock -63.11% below its 50-day simple moving average ($6.18) and -74.15% below its 200-day simple moving average ($8.82). Across its 52-week range of $1.67 to $13.93, GLAS sits at the 5.0% percentile with a 14-day RSI of 13.8 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($2.00 to $2.56).
GLAS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is GLAS stock moving today?
Why GLAS Stock advanced +1.33% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-9% return on capital) under elevated 10-year interest-rate pressure.